PM-43I
CAS No. 1637532-77-4
PM-43I( PM-43-I )
Catalog No. M12467 CAS No. 1637532-77-4
PM-43I is a selective inhibitor of STAT5/6 Src Homology 2 (SH2) domain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1233 | Get Quote |
|
| 50MG | 2502 | Get Quote |
|
| 100MG | 3330 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePM-43I
-
NoteResearch use only, not for human use.
-
Brief DescriptionPM-43I is a selective inhibitor of STAT5/6 Src Homology 2 (SH2) domain.
-
DescriptionPM-43I is a selective inhibitor of STAT5/6 Src Homology 2 (SH2) domain, binds recombinant STAT6 and STAT5B (IC50=1.8 and 3.8 uM) with much lower affinity for STAT3 (IC50=29.9 uM); potently inhibits both STAT5- and STAT6-dependent allergic airway disease in mice; PM-43I reverses preexisting allergic airway disease in mice with a minimum ED50 of 0.25 μg/kg.
-
In VitroWestern Blot Analysis Cell Line:Beas-2B immortalized human airway cells Concentration:0.05, 0.1, 0.5, 1, 2.5, 5 μM Incubation Time:2 h Result:Inhibited STAT6 phosphorylation level to 18%, 21% at 2.5 and 5 μM, respectively.
-
In VivoPM-43I (intranasal administration; 5 μg per mouse; every other day; 18 d) activity is restricted to the lung by intranasal administration. Animal Model:Mice injected with Ovalhumin/Alum Dosage:5 μg per mouse Administration:Intranasal administration; 5 μg per mouse; every other day; 18 days Result:Showed no effect on the sensisization of peripheral spleenocytes to ovalbumin.
-
SynonymsPM-43-I
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1637532-77-4
-
Formula Weight559.559
-
Molecular FormulaC30H30N3O6P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 35 mg/mL (45.00 mM)
-
SMILESO=P(OCOC(C(C)(C)C)=O)(OCOC(C(C)(C)C)=O)C(F)(F)C1=CC=C(/C(C)=C/C(N[C@@H]2C(N(CC(N(C)C3=CC=CC=C3)=O)CCCC2)=O)=O)C=C1
-
Chemical Name(4-((E)-4-(((3S,6S)-6-(methyl(phenyl)carbamoyl)-4-oxo-1,2,3,4,6,7-hexahydroazepino[3,2,1-hi]indol-3-yl)amino)-4-oxobut-2-en-2-yl)phenyl)phosphonic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Knight JM, et al. J Biol Chem. 2018 May 8. pii: jbc.RA117.000567.
molnova catalog
related products
-
N-Methylcytisine
N-Methylcytisine and N, N-dimethylcytisine did not displace 14C-tubocurarine at a concentration of .1 mM, cytisine was the only effective inhibitor of 14C-tubocurarine specific binding (Ki=7 nM).
-
Stafib-1
A potent, selective small molecule inhibitor of transcription factor STAT5b with Ki of 44 nM.
-
NT219
NT219 is a dual inhibitor of insulin receptor substrate 1/2 (IRS1/2) and STAT3, enhances the aggregation of misfolded prion protein NT219 affects the levels of certain molecular chaperones and inhibits STAT3 phosphorylation NT219 is useful for the study of cancer and neurodegenerative diseases.
Cart
sales@molnova.com